25
results
for author:"Szabo S."
in Literature Citations
| Neutralizing anti-vascular endothelial growth factor (VEGF) antibody reduces severity of experimental ulcerative colitis in rats: direct evidence for the pathogenic role of VEGF. Tolstanova G., Khomenko T., Deng X., Chen L., Tarnawski A., Ahluwalia A., Szabo S., Sandor Z. J. Pharmacol. Exp. Ther. 328:749-757(2009) · Mapped (14) |
| Identification of reptilian genes encoding hair keratin-like proteins suggests a new scenario for the evolutionary origin of hair. Eckhart L., Valle L.D., Jaeger K., Ballaun C., Szabo S., Nardi A., Buchberger M., Hermann M., Alibardi L., Tschachler E. Proc. Natl. Acad. Sci. U.S.A. 105:18419-18423(2008) · UniProtKB (5) |
| Dermatofibrosarcoma protuberans COL1A1-PDGFB fusion is identified in virtually all dermatofibrosarcoma protuberans cases when investigated by newly developed multiplex reverse transcription polymerase chain reaction and fluorescence in situ hybridization assays. Patel K.U., Szabo S.S., Hernandez V.S., Prieto V.G., Abruzzo L.V., Lazar A.J., Lopez-Terrada D. Hum. Pathol. 39:184-193(2008) · Mapped (10) |
| The genome and transcriptomes of the anti-tumor agent Clostridium novyi-NT. Bettegowda C., Huang X., Lin J., Cheong I., Kohli M., Szabo S.A., Zhang X., Diaz L.A. Jr., Velculescu V.E., Parmigiani G. et al. Nat. Biotechnol. 24:1573-1580(2006) · UniProtKB (2,305) |
| The consensus coding sequences of human breast and colorectal cancers. Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D., Mandelker D., Leary R.J., Ptak J., Silliman N. et al. |
| Somatic mutations of GUCY2F, EPHA3, and NTRK3 in human cancers. Wood L.D., Calhoun E.S., Silliman N., Ptak J., Szabo S., Powell S.M., Riggins G.J., Wang T.L., Yan H., Gazdar A. et al. Hum. Mutat. 27:1060-1061(2006) · Mapped (10) |
| Genetic polymorphisms of vascular endothelial growth factor in severe pre-eclampsia. Banyasz I., Szabo S., Bokodi G., Vannay A., Vasarhelyi B., Szabo A., Tulassay T., Rigo J. Jr. Mol. Hum. Reprod. 12:233-236(2006) · Mapped (8) |
| Suppression of early growth response factor-1 with egr-1 antisense oligodeoxynucleotide aggravates experimental duodenal ulcers. Khomenko T., Szabo S., Deng X., Jadus M.R., Ishikawa H., Osapay K., Sandor Z., Chen L. Am. J. Physiol. Gastrointest. Liver Physiol. 290:G1211-8(2006) · Mapped (1) |
| T helper cell fate specified by kinase-mediated interaction of T-bet with GATA-3. Hwang E.S., Szabo S.J., Schwartzberg P.L., Glimcher L.H. Science 307:430-433(2005) · Mapped (8) |
| Clinical findings in a carrier of a new mutation in the choroideremia gene. Potter M.J., Wong E., Szabo S.M., McTaggart K.E. Ophthalmology 111:1905-1909(2004) · Mapped (5) |
| The PIK3CA gene is mutated with high frequency in human breast cancers. Bachman K.E., Argani P., Samuels Y., Silliman N., Ptak J., Szabo S., Konishi H., Karakas B., Blair B.G., Lin C. et al. Cancer Biol. Ther. 3:772-775(2004) · Mapped (6) |
| Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis. Bettelli E., Sullivan B., Szabo S.J., Sobel R.A., Glimcher L.H., Kuchroo V.K. J. Exp. Med. 200:79-87(2004) · Mapped (13) |
| Mutational analysis of the tyrosine phosphatome in colorectal cancers. Wang Z., Shen D., Parsons D.W., Bardelli A., Sager J., Szabo S., Ptak J., Silliman N., Peters B.A., van der Heijden M.S. et al. Science 304:1164-1166(2004) · UniProtKB (1) |
| Sustained T-bet expression confers polarized human TH2 cells with TH1-like cytokine production and migratory capacities. Lametschwandtner G., Biedermann T., Schwarzler C., Gunther C., Kund J., Fassl S., Hinteregger S., Carballido-Perrig N., Szabo S.J., Glimcher L.H. et al. J. Allergy Clin. Immunol. 113:987-994(2004) · Mapped (2) |
| Three classes of genes mutated in colorectal cancers with chromosomal instability. Wang Z., Cummins J.M., Shen D., Cahill D.P., Jallepalli P.V., Wang T.-L., Parsons D.W., Traverso G., Awad M., Silliman N. et al. |
| High frequency of mutations of the PIK3CA gene in human cancers. Samuels Y., Wang Z., Bardelli A., Silliman N., Ptak J., Szabo S., Yan H., Gazdar A., Powell S.M., Riggins G.J. et al. |
| Antigen-driven effector CD8 T cell function regulated by T-bet. Sullivan B.M., Juedes A., Szabo S.J., von Herrath M., Glimcher L.H. Proc. Natl. Acad. Sci. U.S.A. 100:15818-15823(2003) · Mapped (3) |
| Effect of cysteamine on redox-sensitive thiol-containing proteins in the duodenal mucosa. Khomenko T., Deng X., Jadus M.R., Szabo S. Biochem. Biophys. Res. Commun. 309:910-916(2003) · Mapped (3) |
| The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease. Neurath M.F., Weigmann B., Finotto S., Glickman J., Nieuwenhuis E., Iijima H., Mizoguchi A., Mizoguchi E., Mudter J., Galle P.R. et al. J. Exp. Med. 195:1129-1143(2002) · Mapped (3) |
| T-bet regulates IgG class switching and pathogenic autoantibody production. Peng S.L., Szabo S.J., Glimcher L.H. Proc. Natl. Acad. Sci. U.S.A. 99:5545-5550(2002) · Mapped (4) |
| Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. Szabo S.J., Sullivan B.M., Stemmann C., Satoskar A.R., Sleckman B.P., Glimcher L.H. Science 295:338-342(2002) · Mapped (3) |
| Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet. Finotto S., Neurath M.F., Glickman J.N., Qin S., Lehr H.A., Green F.H., Ackerman K., Haley K., Galle P.R., Szabo S.J. et al. Science 295:336-338(2002) · Mapped (3) |
| A novel transcription factor, T-bet, directs Th1 lineage commitment. Szabo S.J., Kim S.T., Costa G.L., Zhang X., Fathman C.G., Glimcher L.H. |
| Regulation of the interleukin (IL)-12R beta 2 subunit expression in developing T helper 1 (Th1) and Th2 cells. Szabo S.J., Dighe A.S., Gubler U., Murphy K.M. J. Exp. Med. 185:817-824(1997) · UniProtKB (1) |
| Identification of IL-4 promoter elements conferring Th2-restricted expression during T helper cell subset development. Wenner C.A., Szabo S.J., Murphy K.M. J. Immunol. 158:765-773(1997) · Mapped (1) |
